Atlas Trials

Venetoclax and Dexamethasone for Newly Diagnosed Light-Chain Amyloidosis with Translocation (11;14)

Clinical trial NCT05996406 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05996406
Sponsor
Peking Union Medical College Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Light Chain (AL) AmyloidosisCCND1 TranslocationVenetoclax
Start date
2023-09-07
Primary completion
2024-11-13
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.